Amyotrophic Lateral Sclerosis Market - Forecast(2022 - 2027)

Report Code: HCR 0115 Report Format: PDF + Excel

Amyotrophic Lateral Sclerosis Market Report Overview

Amyotrophic Lateral Sclerosis Market size in 2019 is estimated to be $ 547.2million, growing at a CAGR of 5.8% during the forecast period 2020-2025. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disorder that damages nerve cells in the central nervous system responsible for controlling the voluntary muscles. Symptoms of ALS include muscle twitching and muscles decreasing in size. Advancement in technology and rising geriatric population are the major factors driving the growth of the market. Moreover, rising disposable income and advancement of R&D activities further enhance the overall market demand for amyotrophic lateral sclerosis during the forecast period 2020-2025.

Report Coverage

The report: “Amyotrophic Lateral Sclerosis Market – Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Amyotrophic Lateral Sclerosis Market:
By Drug Type : Riluzole, Nuedexta
By Treatment : Stem Cell Therapy, Chemotherapy, Medication
By Distribution Channel : Hospitals, Diagnostics Centers, Clinics, Retail Pharmacies
By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Key Takeaways

  • In 2019, North America dominates the Amyotrophic Lateral Sclerosis Market owing to increasing healthcare expenditure, and well-established healthcare infrastructure and technological advancement.
  • Advancement in technology and rising geriatric population is driving the market growth of amyotrophic lateral sclerosis.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Amyotrophic Lateral Sclerosis Market report.
  • High costs of treatment and lack of skilled expertise are challenging the growth of the market. 

Drug Type - Segment Analysis

Based on the Drug Type, Amyotrophic Lateral Sclerosis Market is segmented into Riluzole, Nuedexta. The Riluzole segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 4.5% during the forecast period 2020-2025. This is mainly owing to it helps to slow down the worsening of this disease and prolong survival which are contributing to the growth of this segment.

Treatment - Segment Analysis

Based on the Treatment, Amyotrophic Lateral Sclerosis Market is segmented into Stem Cell Therapy, Chemotherapy, Medication. In 2019, medication held the largest share in the Amyotrophic Lateral Sclerosis Market. Medications such as riluzole and edaravone are the only two drugs that are approved by the Food and Drug Administration (FDA) to treat ALS. Moreover, medications help in relieving symptoms, spasticity, panic attacks, pain, and depression is also contributing to the growth of this segment.

Geography - Segment Analysis

North America dominated the Amyotrophic Lateral Sclerosis Market share accounting for 40% of the market in 2019. This is mainly owing to increasing healthcare expenditure, and well- established healthcare infrastructure and technological advancement. According to Centers for Disease Control and Prevention, about 14,000 – 15,000 people in US in 2016 having ALS, almost more than half of these cases could have been avoided with the availability of proper medical treatment.
However, the Asia Pacific region is projected to be the fastest-growing during the forecast period 2020-2025. This is owing to increasing incidence of diseases and increasing growth in research and development activities.

Drivers – Amyotrophic Lateral Sclerosis Market 

  • Advancement in Technology

Advancement in Technology and increasing awareness in the treatment are some factors driving the market growth of this market. Moreover, the FDA also approved NeuRx Diaphragm Pacing System wherein implanted electrodes and batteries are used to contract diaphragm in the ALS population which are increasing the market growth of amyotrophic lateral sclerosis.

  • Increasing Geriatric Population 

Increasing geriatric population increasing the incidence of ALS are some factor driving the growth of this market.  According to the National Institute of Neurological Disorders and Stroke (NINDS) there is a 50% chance of inheriting the genetic mutation for each offspring and eventually developing the disorder which increases the risk of developing the disorder among the geriatric population contributing to the growth of Amyotrophic Lateral Schlerosis Market.

Challenges – Amyotrophic Lateral Schlerosis Market 

High costs of treatment and lack of skilled expertise are challenging the growth of the market. Moreover, owing to high cost there is unawareness about the disease and availability of ineffective diagnosis methods are further restraining its market growth during the forecast period 2020-2025.

Amyotrophic Lateral Schlerosis Industry Outlook

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Amyotrophic Lateral Schlerosis Market. Amyotrophic Lateral Schlerosis top 10 companies are Brainstorm Cell Therapeutics, Sanofi, Biogen, Valeant Pharmaceuticals, Roche, Ionis Pharmaceuticals, Apotex, Mylan Pharma, Sun Pharma, Orion Pharmaceuticals, ViroMed, Mitsubishi Tanabe Pharma America , AB Science and Orphazyme.

Acquisitions/Product Launches:

  • On 25 May 2019, Biogen Inc. launches new product tofersen, an antisense oligonucleotide which are used for the treatment of amyotrophic lateral sclerosis (ALS) in adults with a confirmed superoxide dismutase 1 (SOD1) mutation.
  • On 10 April 2018, Biogen has acquisition with Ionic Pharmaceuticals and develop neurological drugs i.e Spinraza to develop the spinal muscular atrophy (SMA) treatment.
1. Amyotrophic Lateral Sclerosis Market Overview
    1.1 Definitions and Scope
2. Amyotrophic Lateral Sclerosis Market Executive Summary
    2.1 Market Size and Key Trends 
    2.2 Key trends by Drug Type
    2.3 Key trends by Treatment
    2.4 Key trends by Distribution Channel
    2.5 Key trends by Geography
3. Amyotrophic Lateral Sclerosis Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Amyotrophic Lateral Sclerosis Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Amyotrophic Lateral Sclerosis Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Amyotrophic Lateral Sclerosis Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Amyotrophic Lateral Sclerosis Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Synthetic Vitamin E Market– By Drug Type (Market Size -$Million/$Billion)
    8.1 Riluzole
    8.2 Nuedexta
9. Amyotrophic Lateral Sclerosis Market– By Treatment (Market Size -$Million/$Billion)
    9.1 Stem Cell Therapy
    9.2 Chemotherapy
    9.3 Medication
10. Amyotrophic Lateral Sclerosis Market– By Distribution Channel (Market Size -$Million/$Billion)
    10.1 Hospitals
    10.2 Diagnostics Centers
    10.3 Clinics
    10.4 Retail Pharmacies
11. Amyotrophic Lateral Sclerosis Market- By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Amyotrophic Lateral Sclerosis Market Entropy
13. Amyotrophic Lateral Sclerosis Market- Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Amyotrophic Lateral Sclerosis Market- Key Company List by Country Premium Premium
15. Amyotrophic Lateral Sclerosis Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table1 Amyotrophic Lateral Sclerosis Market Overview 2021-2026
Table2 Amyotrophic Lateral Sclerosis Market Leader Analysis 2018-2019 (US$)
Table3 Amyotrophic Lateral Sclerosis MarketProduct Analysis 2018-2019 (US$)
Table4 Amyotrophic Lateral Sclerosis MarketEnd User Analysis 2018-2019 (US$)
Table5 Amyotrophic Lateral Sclerosis MarketPatent Analysis 2013-2018* (US$)
Table6 Amyotrophic Lateral Sclerosis MarketFinancial Analysis 2018-2019 (US$)
Table7 Amyotrophic Lateral Sclerosis Market Driver Analysis 2018-2019 (US$)
Table8 Amyotrophic Lateral Sclerosis MarketChallenges Analysis 2018-2019 (US$)
Table9 Amyotrophic Lateral Sclerosis MarketConstraint Analysis 2018-2019 (US$)
Table10 Amyotrophic Lateral Sclerosis Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11 Amyotrophic Lateral Sclerosis Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12 Amyotrophic Lateral Sclerosis Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13 Amyotrophic Lateral Sclerosis Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14 Amyotrophic Lateral Sclerosis Market Degree of Competition Analysis 2018-2019 (US$)
Table15 Amyotrophic Lateral Sclerosis MarketValue Chain Analysis 2018-2019 (US$)
Table16 Amyotrophic Lateral Sclerosis MarketPricing Analysis 2021-2026 (US$)
Table17 Amyotrophic Lateral Sclerosis MarketOpportunities Analysis 2021-2026 (US$)
Table18 Amyotrophic Lateral Sclerosis MarketProduct Life Cycle Analysis 2021-2026 (US$)
Table19 Amyotrophic Lateral Sclerosis MarketSupplier Analysis 2018-2019 (US$)
Table20 Amyotrophic Lateral Sclerosis MarketDistributor Analysis 2018-2019 (US$)
Table21 Amyotrophic Lateral Sclerosis Market Trend Analysis 2018-2019 (US$)
Table22 Amyotrophic Lateral Sclerosis Market Size 2018 (US$)
Table23 Amyotrophic Lateral Sclerosis Market Forecast Analysis 2021-2026 (US$)
Table24 Amyotrophic Lateral Sclerosis Market Sales Forecast Analysis 2021-2026 (Units)
Table25 Top Companies 2018 (US$)Amyotrophic Lateral Sclerosis Market, Revenue & Volume,,
Table26 Product Launch 2018-2019Amyotrophic Lateral Sclerosis Market, Revenue & Volume,,
Table27 Mergers & Acquistions 2018-2019Amyotrophic Lateral Sclerosis Market, Revenue & Volume,,


List of Figures

Figure 1 Overview of Amyotrophic Lateral Sclerosis Market 2021-2026
Figure 2 Market Share Analysis for Amyotrophic Lateral Sclerosis Market 2018 (US$)
Figure 3 Product Comparison in Amyotrophic Lateral Sclerosis Market 2018-2019 (US$)
Figure 4 End User Profile for Amyotrophic Lateral Sclerosis Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Amyotrophic Lateral Sclerosis Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Amyotrophic Lateral Sclerosis Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Amyotrophic Lateral Sclerosis Market 2018-2019
Figure 8 Ecosystem Analysis in Amyotrophic Lateral Sclerosis Market2018
Figure 9 Average Selling Price in Amyotrophic Lateral Sclerosis Market 2021-2026
Figure 10 Top Opportunites in Amyotrophic Lateral Sclerosis Market 2018-2019
Figure 11 Market Life Cycle Analysis in Amyotrophic Lateral Sclerosis Market
Figure 12 Global Amyotrophic Lateral Sclerosis Market - By Geography
Figure 13 Global Amyotrophic Lateral Sclerosis Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 14 Global Amyotrophic Lateral Sclerosis Market CAGR, By Geography, 2021-2026 (%)
Figure 15 North America Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 16 US Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 17 US GDP and Population, 2018-2019 ($)
Figure 18 US GDP – Composition of 2018, By Sector of Origin
Figure 19 US Export and Import Value & Volume, 2018-2019 ($)
Figure 20 Canada Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 21 Canada GDP and Population, 2018-2019 ($)
Figure 22 Canada GDP – Composition of 2018, By Sector of Origin
Figure 23 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 24 Mexico Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 25 Mexico GDP and Population, 2018-2019 ($)
Figure 26 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 27 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 28 South America Amyotrophic Lateral Sclerosis MarketSouth America 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 29 Brazil Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 30 Brazil GDP and Population, 2018-2019 ($)
Figure 31 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 32 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 33 Venezuela Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 34 Venezuela GDP and Population, 2018-2019 ($)
Figure 35 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 36 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 37 Argentina Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 38 Argentina GDP and Population, 2018-2019 ($)
Figure 39 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 40 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 41 Ecuador Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 42 Ecuador GDP and Population, 2018-2019 ($)
Figure 43 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 44 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 45 Peru Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 46 Peru GDP and Population, 2018-2019 ($)
Figure 47 Peru GDP – Composition of 2018, By Sector of Origin
Figure 48 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 49 Colombia Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 50 Colombia GDP and Population, 2018-2019 ($)
Figure 51 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 52 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 53 Costa Rica Amyotrophic Lateral Sclerosis MarketCosta Rica 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 54 Costa Rica GDP and Population, 2018-2019 ($)
Figure 55 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 56 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 57 Europe Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 58 U.K Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 59 U.K GDP and Population, 2018-2019 ($)
Figure 60 U.K GDP – Composition of 2018, By Sector of Origin
Figure 61 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 62 Germany Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 63 Germany GDP and Population, 2018-2019 ($)
Figure 64 Germany GDP – Composition of 2018, By Sector of Origin
Figure 65 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 66 Italy Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 67 Italy GDP and Population, 2018-2019 ($)
Figure 68 Italy GDP – Composition of 2018, By Sector of Origin
Figure 69 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 70 France Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 71 France GDP and Population, 2018-2019 ($)
Figure 72 France GDP – Composition of 2018, By Sector of Origin
Figure 73 France Export and Import Value & Volume, 2018-2019 ($)
Figure 74 Netherlands Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 75 Netherlands GDP and Population, 2018-2019 ($)
Figure 76 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 77 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 78 Belgium Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 79 Belgium GDP and Population, 2018-2019 ($)
Figure 80 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 81 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 82 Spain Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 83 Spain GDP and Population, 2018-2019 ($)
Figure 84 Spain GDP – Composition of 2018, By Sector of Origin
Figure 85 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 86 Denmark Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 87 Denmark GDP and Population, 2018-2019 ($)
Figure 88 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 89 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 90 APAC Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 91 China Amyotrophic Lateral Sclerosis MarketValue & Volume, 2021-2026
Figure 92 China GDP and Population, 2018-2019 ($)
Figure 93 China GDP – Composition of 2018, By Sector of Origin
Figure 94 China Export and Import Value & Volume, 2018-2019 ($)Amyotrophic Lateral Sclerosis MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 95 Australia Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 96 Australia GDP and Population, 2018-2019 ($)
Figure 97 Australia GDP – Composition of 2018, By Sector of Origin
Figure 98 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 99 South Korea Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 100 South Korea GDP and Population, 2018-2019 ($)
Figure 101 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 102 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 103 India Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 104 India GDP and Population, 2018-2019 ($)
Figure 105 India GDP – Composition of 2018, By Sector of Origin
Figure 106 India Export and Import Value & Volume, 2018-2019 ($)
Figure 107 Taiwan Amyotrophic Lateral Sclerosis MarketTaiwan 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 108 Taiwan GDP and Population, 2018-2019 ($)
Figure 109 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 110 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 111 Malaysia Amyotrophic Lateral Sclerosis MarketMalaysia 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 112 Malaysia GDP and Population, 2018-2019 ($)
Figure 113 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 114 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 115 Hong Kong Amyotrophic Lateral Sclerosis MarketHong Kong 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 116 Hong Kong GDP and Population, 2018-2019 ($)
Figure 117 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 118 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 119 Middle East & Africa Amyotrophic Lateral Sclerosis MarketMiddle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 120 Russia Amyotrophic Lateral Sclerosis MarketRussia 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 121 Russia GDP and Population, 2018-2019 ($)
Figure 122 Russia GDP – Composition of 2018, By Sector of Origin
Figure 123 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 124 Israel Amyotrophic Lateral Sclerosis Market Value & Volume, 2021-2026 ($)
Figure 125 Israel GDP and Population, 2018-2019 ($)
Figure 126 Israel GDP – Composition of 2018, By Sector of Origin
Figure 127 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 128 Entropy Share, By Strategies, 2018-2019* (%)Amyotrophic Lateral Sclerosis Market
Figure 129 Developments, 2018-2019*Amyotrophic Lateral Sclerosis Market
Figure 130 Company 1 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 131 Company 1 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 132 Company 1 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 133 Company 2 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 134 Company 2 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135 Company 2 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 136 Company 3Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 137 Company 3Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138 Company 3Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 139 Company 4 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 140 Company 4 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141 Company 4 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 142 Company 5 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 143 Company 5 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144 Company 5 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 145 Company 6 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 146 Company 6 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147 Company 6 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 148 Company 7 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 149 Company 7 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150 Company 7 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 151 Company 8 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 152 Company 8 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153 Company 8 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 154 Company 9 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 155 Company 9 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156 Company 9 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 157 Company 10 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 158 Company 10 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159 Company 10 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 160 Company 11 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 161 Company 11 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162 Company 11 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 163 Company 12 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 164 Company 12 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165 Company 12 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 166 Company 13Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 167 Company 13Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168 Company 13Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 169 Company 14 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 170 Company 14 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171 Company 14 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)
Figure 172 Company 15 Amyotrophic Lateral Sclerosis Market Net Revenue, By Years, 2018-2019* ($)
Figure 173 Company 15 Amyotrophic Lateral Sclerosis Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174 Company 15 Amyotrophic Lateral Sclerosis Market Net Sales Share, By Geography, 2018 (%)